Binx — COVID-19 Testing Platform

Organization Name 
Award Date 
11/2020
Grant Amount 
$2,000,000
Purpose 
To support work on a COVID-19 diagnostic platform.
Topic (focus area) 

Grant investigators: Heather Youngs and Chris Somerville

This page was reviewed but not written by the grant investigators. Binx staff also reviewed this page prior to publication.

Open Philanthropy recommended an investment of $2,000,000 in Binx to support work to incorporate Sherlock Biosciences’s COVID-19 assay into Binx’s point-of-care diagnostic platform. This funding is intended to support work to obtain Emergency Use Authorization approval of the Binx-Sherlock Biosciences COVID-19 testing platform.

This falls within our work on scientific research, specifically within our interest in advancing science supporting biosecurity and pandemic preparedness.